Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 2 of 2

Figure 1: A potential care model for hepatitis C virus (HCV) in community pharmacy

Chronic hepatitis C virus (HCV) is estimated to affect 2–3% of the world population and numerous barriers exist to testing and treatment, especially in people who inject drugs (PWID). In the UK, a series of national action plans and National Institute for Health and Care Excellence (NICE) guidance have urged action to increase HCV testing, and this has prompted initiatives including GP record screening for people at risk of HCV, screening in emergency departments, screening in prisons and widespread testing in drug support centres.There is also growing evidence of the potential effectiveness of HCV testing in community pharmacies.

Source  Illustrations by Juliet Percival